Consolidated Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7580405

Concept 2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,880,529,000 JPY
-1,572,198,000 JPY
Depreciation
82,770,000 JPY
Impairment losses
194,829,000 JPY
Increase (decrease) in provision for retirement benefits
1,677,000 JPY
Interest and dividend income
-1,762,000 JPY
Decrease (increase) in trade receivables
76,171,000 JPY
Subtotal
-1,468,048,000 JPY
Income taxes paid
-3,670,000 JPY
Decrease (increase) in inventories
27,569,000 JPY
Increase (decrease) in trade payables
19,564,000 JPY
Net cash provided by (used in) operating activities
-1,457,571,000 JPY
Other, net
-17,092,000 JPY
Interest and dividends received
63,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-173,164,000 JPY
Net cash provided by (used in) investing activities
-185,115,000 JPY
Loan advances
-8,200,000 JPY
Proceeds from collection of loans receivable
10,000,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
15,810,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,626,876,000 JPY
Cash and cash equivalents
4,901,177,000 JPY
6,528,053,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.